Celator Pharmaceuticals

Operator of a pharmaceutical company intended to improve clinical outcomes.

Launch date

1999

Market cap

Enterprise valuation

$1.5b (Public information from May 2016)

Dublin County Dublin (HQ)

Date	Investors	Amount	Round
-	Prospect Venture Partners Adams Street Partners Waud Capital Partners Beecken Petty O'Keefe & Company Longitude Capital	N/A	-
Jan 2003	Business Development Bank of Canada (BDC)	N/A	Seed
May 2005	TL Ventures Domain Associates	$20.0m	Series B
Aug 2007	N/A	$10.0m	Series C
Jul 2008	Ventures West	$22.5m	Series C
May 2010	N/A	$2.5m	Early VC
Sep 2010	Thomas McNerney & Partners	$20.0m	Series D
Dec 2011	N/A	$2.6m	Early VC
Apr 2013	ROTH Capital Partners Valence Life Sciences	$39.3m	Growth Equity VC
Sep 2013	N/A	N/A	IPO
Jun 2014	Hercules Capital	$15.0m	Debt
May 2016	Jazz Pharmaceuticals	$1.5b Valuation: $1.5b	Acquisition
Total Funding		$117m